Annual Working Capital
$229.34 M
-$42.92 M-15.76%
December 31, 2023
Summary
- As of February 23, 2025, SPRY annual working capital is $229.34 million, with the most recent change of -$42.92 million (-15.76%) on December 31, 2023.
- During the last 3 years, SPRY annual working capital has risen by +$211.16 million (+1162.02%).
- SPRY annual working capital is now -15.76% below its all-time high of $272.26 million, reached on December 31, 2022.
Performance
SPRY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$192.17 M
-$21.85 M-10.21%
September 30, 2024
Summary
- As of February 23, 2025, SPRY quarterly working capital is $192.17 million, with the most recent change of -$21.85 million (-10.21%) on September 30, 2024.
- Over the past year, SPRY quarterly working capital has stayed the same.
- SPRY quarterly working capital is now -29.42% below its all-time high of $272.26 million, reached on December 31, 2022.
Performance
SPRY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SPRY Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.8% | 0.0% |
| 3 y3 years | +1162.0% | 0.0% |
| 5 y5 years | +1162.0% | 0.0% |
SPRY Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.8% | +336.5% | -29.4% | +406.7% |
| 5 y | 5-year | -15.8% | +1162.0% | -29.4% | +406.7% |
| alltime | all time | -15.8% | +1162.0% | -29.4% | +406.7% |
ARS Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $192.17 M(-10.2%) |
| Jun 2024 | - | $214.01 M(-3.8%) |
| Mar 2024 | - | $222.53 M(-3.0%) |
| Dec 2023 | $229.34 M | $229.34 M(-1.7%) |
| Sep 2023 | - | $233.29 M(-4.8%) |
| Jun 2023 | - | $244.98 M(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $257.51 M(-5.4%) |
| Dec 2022 | $272.26 M(+418.2%) | $272.26 M(+617.8%) |
| Jun 2022 | - | $37.93 M(-27.8%) |
| Dec 2021 | $52.54 M(+189.1%) | - |
| Dec 2021 | - | $52.54 M |
| Dec 2020 | $18.17 M | - |
FAQ
- What is ARS Pharmaceuticals annual working capital?
- What is the all time high annual working capital for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual working capital year-on-year change?
- What is ARS Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly working capital year-on-year change?
What is ARS Pharmaceuticals annual working capital?
The current annual working capital of SPRY is $229.34 M
What is the all time high annual working capital for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual working capital is $272.26 M
What is ARS Pharmaceuticals annual working capital year-on-year change?
Over the past year, SPRY annual working capital has changed by -$42.92 M (-15.76%)
What is ARS Pharmaceuticals quarterly working capital?
The current quarterly working capital of SPRY is $192.17 M
What is the all time high quarterly working capital for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly working capital is $272.26 M
What is ARS Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, SPRY quarterly working capital has changed by $0.00 (0.00%)